935106861
info@markelab.com
Precio
618.75€ (96 tests)
B-cell Leukemia/Lymphoma 2 ELISA Kit is an ELISA Kit against B-cell Leukemia/Lymphoma 2.
BCL2 apoptosis regulator (BCL2) is a key anti-apoptotic protein that plays a central role in regulating cell survival by preventing mitochondrial-mediated apoptosis BCL2 functions by inhibiting the release of pro-apoptotic factors, such as cytochrome c, from the mitochondria, thus preventing caspase activation and cell death It is highly expressed in various tissues, particularly in immune cells and neurons, where it protects against apoptosis and supports cell longevity Dysregulation of BCL2 expression has been associated with several diseases, including cancer, where its overexpression allows tumor cells to evade cell death, contributing to tumor progression and resistance to therapy BCL2 is also implicated in neurodegenerative diseases, where its dysfunction can lead to excessive neuronal death BCL2 interacts with other members of the Bcl-2 family, including pro-apoptotic proteins like BAX, to finely tune apoptotic signaling and maintain cellular homeostasis Its role in regulating apoptosis and survival pathways makes BCL2 a critical factor in development, aging, and disease management
ELISA Kits
Apoptosis Regulator Bcl-2 (BCL2)
Guinea pig
0.156 ng/ml - 10 ng/ml
< 0.1 ng/ml
Sandwich
Quantitative
Colorimetric
Serum, plasma, other biological fluids
96 tests
Bcl-2,PPP1R50,B-Cell CLL/Lymphoma 2
Enviado a 4 °C. Una vez recibido, almacene el kit de acuerdo con las instrucciones citadas en el manual del kit
BCL2
No
This product is for research use only. <p></p> The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments. <p></p> Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más